A Phase 3 Study of Tenapanor to Treat Hyperphosphatemia in ESRD Patients on Dialysis

Clinical trial NCT03427125 · COMPLETED

Trial details

NCT number: NCT03427125
Sponsor: Ardelyx
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hyperphosphatemia

Start date: 2018-01-08
Primary completion: 2019-11-15
Enrollment: 1559

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.